Cypherpunk Technologies Inc. (CYPH) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cypherpunk Technologies Inc. (formerly Leap Therapeutics, Inc.) on December 30, 2025, reporting events occurring on December 23, 2025. The Company is incorporated in Delaware and trades on The Nasdaq Capital Market under the symbol "CYPH". The filing details a material definitive agreement regarding equity compensation for a consultant.
Key Financial Metrics
The filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the terms of a Restricted Stock Unit (RSU) grant and the termination of a prior agreement.
Material Changes and Agreements
- RSU Grant and Restructuring: On December 23, 2025, the Compensation Committee approved a grant of 5,448,157 RSUs to CoinXit Ltd. under the 2025 Equity Incentive Plan.
- Termination of Prior Awards: This new grant replaced and terminated a previous award of 2,411,700 RSUs granted in November 2025 and satisfied the obligation to grant an additional 3,036,457 RSUs. The total count (5,448,157) equals the sum of the cancelled and required additional units.
- Vesting Schedule: The RSUs vest 12/36ths on October 8, 2026, followed by 1/36th monthly thereafter, contingent on continuous service.
- Acceleration Clause: If CoinXit is terminated by the Company other than for "Cause," or terminates for "Good Reason," all unvested RSUs automatically become fully vested.
- Settlement Terms: Vested RSUs settle on the earliest of: CoinXit's cessation of service, June 8, or December 8 of the applicable year.
Management Commentary and Corporate Governance
The filing notes that Mr. Khing Oei, the sole director and stockholder of CoinXit, was appointed to the Board as an "Investor Designee" by Winklevoss Treasury Investments, LLC (WTI) on November 11, 2025, and elected as Chairman of the Board. This appointment was part of a Lead Investor Agreement connected to a private placement equity financing closed on October 8, 2025.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2025 Equity Incentive Plan to ensure the 5,448,157 RSU grant does not exceed available reserves.
- Review the full text of the Restricted Stock Unit Grant Agreement (Exhibit 10.1) for specific definitions of "Cause" and "Good Reason" which trigger acceleration.
- Confirm the impact of this grant on the Company's pro forma share count and potential dilution to existing shareholders.
- Assess the relationship between CoinXit Ltd. and Winklevoss Treasury Investments, LLC, given the Board appointment and financing history.